UK drugmaker AstraZeneca profit slumps but sales jump
AstraZeneca’s first-quarter net profit dropped due to restructuring and legal costs associated with its massive takeover of US biotech firm Alexion, but sales rose. In the three months to the end of March, profit after tax fell by 75% to $386 million (366 million euros), compared to the same period the previous year. Sales of … Read more
